デフォルト表紙
市場調査レポート
商品コード
1609591

医療シミュレーションの市場規模、シェア、動向分析レポート:製品・サービス別、技術別、最終用途別、地域別、セグメント予測、2025年~2030年

Medical Simulation Market Size, Share & Trends Analysis Report By Product & Services (Healthcare Simulation Software, Simulation Training Services), By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 100 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療シミュレーションの市場規模、シェア、動向分析レポート:製品・サービス別、技術別、最終用途別、地域別、セグメント予測、2025年~2030年
出版日: 2024年11月06日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療シミュレーション市場の成長と動向:

世界の医療シミュレーション市場規模は、2030年までに41億9,000万米ドルに達すると予測されます。

2025年から2030年にかけてのCAGRは16.80%で市場は拡大すると予測されます。最近の技術動向では、強化型人工呼吸装置、心臓補助装置、心エコー技術など、新しい医療機器や高度な手技の使用が増加しており、顧客トレーニングや社内の製品開発にシミュレーションなどの高度なトレーニングソリューションの必要性が高まっています。認証機関や規制機関は、破壊的な新技術を採用する前に医師や臨床医がトレーニングを受けることを厳しく推奨しています。実際の患者を使った実地学習は代替できないが、シミュレーショントレーニングは安全な学習条件を提供します。シミュレーショントレーニングでは患者が危険にさらされることはないため、学生や研修医がこの段階で間違いを犯すことは学習プロセスの重要な一部となります。

医療シミュレーションの学習管理技術を扱うEducation Management Solutions, LLC社は、医療教育用のCOVID-19有事対応ワークフローをリリースしました。CAEヘルスケアは、教育者を支援するための無料のウェビナー、SCE、アウトリーチツールキットを提供し、パンデミックに対応しました。このような要因が、パンデミック時の医療シミュレーションサービスの需要を押し上げました。

市場競争は激しいです。最も注目すべき市場参入企業は、CAE、Laerdal Medical、3D Systems、Simulab Corporation、Limbs &Things Ltd、Mentice AB、Simulaids、Gaumard Scientific Company、Surgical Science Sweden AB、京都科学株式会社であり、市場への製品提供によってかなりのシェアを占めています。市場のリーダーたちは、より大きなシェアを獲得するために、広範な流通システムの確立やM&Aを行っています。例えば、2021年1月、Gaumard Scientific社は、Pediatric HAL向けの超音波システムと小児救急シナリオモジュールを発表しました。

医療シミュレーション市場レポートハイライト

  • ヘルスケア解剖モデルは、2024年に市場全体の製品・サービスセグメントを支配しました。これらのシミュレータは、製造業や研究産業で試験を実施するのに有益であることが証明されているからです。
  • 病院のエンドユーザー分野は、予測期間中最も速いCAGR 16.6%で拡大すると予測されています。成長の要因としては、高度な学習への漸進的なシフトとエラーの最小化への注目の高まりが挙げられます。
  • 手順リハーサル技術は最大の技術セグメントになると予想されます。患者の安全に対する要求の高まりにつながる医療過誤の増加が、手順リハーサル技術の需要を押し上げると予想されます。
  • アジア太平洋地域は、ヘルスケアIT支出の増加と急速に進化するヘルスケアインフラにより、今後数年間で急成長を記録すると予測されています。
  • 2022年2月、Surgical Science社はMimic Technologies社の傘下に入り、ロボット手術分野での足場を固めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析ツール
    • ポーターのファイブフォース分析
    • PESTL分析
  • テクノロジーの概要
    • 仮想現実(VR)と拡張現実(AR)
    • 人工知能(AI)
    • ゲーミフィケーション
    • シミュレータ開発における多分野アプローチの活用
    • 3Dプリント
    • HCIT/EMR-EHR
  • COVID-19パンデミックの影響
  • 地域レベルの製品タイプ別の推定エンドユーザー数

第4章 医療シミュレーション市場:製品・サービスの推定・動向分析

  • 医療シミュレーション製品およびサービス市場:セグメントダッシュボード
  • 2024年と2030年の製品動向と市場シェア分析
    • ヘルスケア解剖モデル
    • ヘルスケアシミュレーションソフトウェア(Webベースのシミュレーターを含む)
    • シミュレーショントレーニングサービス

第5章 医療シミュレーション市場:技術推定・動向分析

  • 医療シミュレーション技術市場:セグメントダッシュボード
  • 技術動向と市場シェア分析、2024年と2030年
    • 仮想患者シミュレーション
    • 3Dプリント
    • 手順リハーサル技術

第6章 医療シミュレーション市場:最終用途の推定・動向分析

  • 医療シミュレーション最終用途市場:セグメントダッシュボード
  • 2024年と2030年の機器の動きと市場シェア分析
    • 病院
    • 調査
    • 学術機関
    • 軍事組織

第7章 地域展望

  • 地域展望
  • 地域別の医療シミュレーション市場:マーケットプレースの主要なポイント
  • 北米
    • 北米医療シミュレーション市場の推定と予測、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の医療シミュレーション市場の推定と予測、2018年-2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋地域の医療シミュレーション市場の推定と予測、2018年-2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの医療シミュレーション市場の推定と予測、2018年-2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ医療シミュレーション市場の推定と予測、2018-2030
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • 企業市況分析、2024年
  • 企業プロファイル/上場企業
    • CAE, Inc.(Madison Industries acquired CAE healthcare division in October 2023)
    • Laerdal Medical
    • 3D Systems, Inc.
    • Simulab Corporation
    • Limbs &Things Ltd
    • Simulaids
    • Kyoto Kagaku Co., Ltd
    • Gaumard Scientific
    • Mentice
    • Surgical Science Sweden AB
    • Intelligent Ultrasound
    • Operative Experience, Inc.
    • Cardionics, Inc.
    • VirtaMed AG
    • SYNBONE AG
    • IngMar Medical
    • TruCorp
    • KaVo Dental
    • Simendo
    • Haag-Streit
    • Symgery
    • HRV Simulation
    • Synaptive Medical
    • Inovus Limited
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global medical simulation market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 4 Global medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America medical simulation market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 8 North America medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 9 North America medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 11 U.S. medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 14 Canada medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Canada medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 17 Mexico medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Mexico medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe medical simulation market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 21 Europe medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Europe medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 24 UK medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 25 UK medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 27 Germany medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Germany medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 30 France medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 31 France medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 33 Italy medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 34 Italy medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 36 Spain medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 37 Spain medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Spain medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Denmark medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 40 Denmark medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Denmark medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Sweden medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 43 Sweden medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Sweden medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Norway medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 46 Norway medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Norway medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific medical simulation market, by country, 2018 - 2030 (USD Million)
  • Table 49 Million)
  • Table 50 Asia Pacific medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 53 China medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 54 China medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 55 China medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Japan medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 57 Japan medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Japan medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 59 India medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 60 India medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 61 India medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 62 South Korea medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 63 South Korea medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 64 South Korea medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Australia medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 66 Australia medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Australia medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Thailand medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 69 Thailand medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 70 Thailand medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Latin America medical simulation market, by country, 2018 - 2030 (USD Million)
  • Table 72 Latin America medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 73 Latin America medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Latin America medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Brazil medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 76 Brazil medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Brazil medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Argentina medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 79 Argentina medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Argentina medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 81 MEA medical simulation market, by country, 2018 - 2030 (USD Million)
  • Table 82 MEA medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 83 MEA medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 84 MEA medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 85 South Africa medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 86 South Africa medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 87 South Africa medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 91 UAE medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 92 UAE medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 93 UAE medical simulation market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait medical simulation market, by product & services, 2018 - 2030 (USD Million)
  • Table 95 Kuwait medical simulation market, by technology, 2018 - 2030 (USD Million)
  • Table 96 Kuwait medical simulation market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Medical simulation market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Supply-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Market snapshot
  • Fig. 11 Segment outlook
  • Fig. 12 Segment outlook
  • Fig. 13 Competitive scenario
  • Fig. 14 Market dynamics
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Medical simulation market: Porter's five forces analysis
  • Fig. 18 Medical simulation market: PESTLE analysis
  • Fig. 19 Medical simulation product & services market: segment dashboard
  • Fig. 20 Medical simulation product & services market: Market share analysis, 2024 & 2030
  • Fig. 21 Healthcare anatomical models' market, 2018 - 2030 (USD Million)
  • Fig. 22 Type 1 market 2018 - 2030 (USD Million)
  • Fig. 23 Patient simulators market 2018 - 2030 (USD Million)
  • Fig. 24 Adult market 2018 - 2030 (USD Million)
  • Fig. 25 Pediatrics and baby care market 2018 - 2030 (USD Million)
  • Fig. 26 Task trainers market 2018 - 2030 (USD Million)
  • Fig. 27 Fidelity market 2018 - 2030 (USD Million)
  • Fig. 28 Low-fidelity market 2018 - 2030 (USD Million)
  • Fig. 29 Medium-fidelity simulators market 2018 - 2030 (USD Million)
  • Fig. 30 High-fidelity simulators market 2018 - 2030 (USD Million)
  • Fig. 31 Type 2 market 2018 - 2030 (USD Million)
  • Fig. 32 Interventional/surgical simulators market 2018 - 2030 (USD Million)
  • Fig. 33 Laproscopic surgical simulators market 2018 - 2030 (USD Million)
  • Fig. 34 Gynecological simulators market 2018 - 2030 (USD Million)
  • Fig. 35 Cardiovascular simulators market 2018 - 2030 (USD Million)
  • Fig. 36 Arthroscopic surgical simulators market 2018 - 2030 (USD Million)
  • Fig. 37 Spine surgical simulators market 2018 - 2030 (USD Million)
  • Fig. 38 Other interventional/surgical simulators market 2018 - 2030 (USD Million)
  • Fig. 39 Endovascular simulators market 2018 - 2030 (USD Million)
  • Fig. 40 Ultrasound simulators market 2018 - 2030 (USD Million)
  • Fig. 41 Dental simulators market 2018 - 2030 (USD Million)
  • Fig. 42 Eye simulators market 2018 - 2030 (USD Million)
  • Fig. 43 Healthcare simulation software market, 2018 - 2030 (USD Million)
  • Fig. 44 Simulation training services market, 2018 - 2030 (USD Million)
  • Fig. 45 Medical simulation technology market: Segment dashboard
  • Fig. 46 Medical simulation market Technology: Market share analysis, 2024 & 2030
  • Fig. 47 Virtual patient simulation market, 2018 - 2030 (USD Million)
  • Fig. 48 3D printing market 2018 - 2030 (USD Million)
  • Fig. 49 Procedure rehearsal technology market 2018 - 2030 (USD Million)
  • Fig. 50 Medical simulation end use market: Segment dashboard
  • Fig. 51 Medical simulation by end use: Market share analysis, 2024 & 2030
  • Fig. 52 Hospitals market 2018 - 2030 (USD Million)
  • Fig. 53 Research market 2018 - 2030 (USD Million)
  • Fig. 54 Medical device companies market 2018 - 2030 (USD Million)
  • Fig. 55 Others market 2018 - 2030 (USD Million)
  • Fig. 56 Academic institutes market 2018 - 2030 (USD Million)
  • Fig. 57 Military organizations market, 2018 - 2030 (USD Million)
  • Fig. 58 Medical simulation market revenue, by region
  • Fig. 59 Regional key marketplace takeaway
  • Fig. 60 Regional key marketplace takeaway
  • Fig. 61 North America medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 62 U.S. Key country dynamics
  • Fig. 63 U.S. medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 64 Canada Key country dynamics
  • Fig. 65 Canada medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 66 Europe medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 67 UK Key country dynamics
  • Fig. 68 UK medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 69 Germany Key country dynamics
  • Fig. 70 Germany medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 71 France Key country dynamics
  • Fig. 72 France medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 73 Italy Key country dynamics
  • Fig. 74 Italy medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 75 Spain Key country dynamics
  • Fig. 76 Spain medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 77 Denmark Key country dynamics
  • Fig. 78 Denmark medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 79 Sweden Key country dynamics
  • Fig. 80 Sweden medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 81 Norway Key country dynamics
  • Fig. 82 Norway medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 83 Asia Pacific medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 84 Japan Key country dynamics
  • Fig. 85 Japan medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 86 China Key country dynamics
  • Fig. 87 China medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 88 India Key country dynamics
  • Fig. 89 India medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 90 Australia Key country dynamics
  • Fig. 91 Australia medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 92 South Korea Key country dynamics
  • Fig. 93 South Korea medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 94 Thailand Key country dynamics
  • Fig. 95 Thailand medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 96 Latin America medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 97 Brazil Key country dynamics
  • Fig. 98 Brazil medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 99 Mexico Key country dynamics
  • Fig. 100 Mexico medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 101 Argentina Key country dynamics
  • Fig. 102 Argentina medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 103 MEA medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 104 South Africa Key country dynamics
  • Fig. 105 South Africa medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 106 Saudi Arabia Key country dynamics
  • Fig. 107 Saudi Arabia medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 108 UAE Key country dynamics
  • Fig. 109 UAE medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 110 Kuwait Key country dynamics
  • Fig. 111 Kuwait medical simulation market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 112 Company market position analysis, 2024
目次
Product Code: GVR-2-68038-582-3

Medical Simulation Market Growth & Trends:

The global medical simulation market size is expected to reach a value of USD 4.19 billion by 2030. The market is expected to expand at a CAGR of 16.80% from 2025 to 2030. With recent technological advancements, the use of new medical devices and advanced procedures, such as enhanced mechanical ventilation devices, cardiac assist devices, and intra-cardiac echocardiography technology, is increasing; which drives the need for advanced training solutions, such as simulation, for customer training and internal product development. Certification and regulatory agencies are strictly recommending that physicians and clinicians be trained before the adoption of new, disruptive technologies. Although hands-on learning with real patients cannot be replaced, simulation training offers safe learning conditions. Students and medical residents making mistakes in this phase is an important part of the learning process, as in simulation training patients are not put at risk.

Education Management Solutions, LLC- a company dealing in medical simulation learning management technology-released workflows that were COVID-19 contingency ready for healthcare education. CAE Healthcare responded to the pandemic by helping with a complimentary webinar, SCE, and outreach toolkit to assist educators. Such factors boosted the demand for medical simulation services during the pandemic.

The market is very competitive. The most notable market participants are CAE, Laerdal Medical, 3D Systems, Simulab Corporation, Limbs & Things Ltd, Mentice AB, Simulaids, Gaumard Scientific Company, Surgical Science Sweden AB, Kyoto Kagaku Co., Ltd and account for a considerable share owing to their product offerings to the market. Market leaders are involved in the establishment of extensive distribution systems as well as in mergers and acquisitions to capture a larger share of the market. For instance, in January 2021, Gaumard Scientific Company revealed its ultrasound system and pediatric emergency scenario modules for Pediatric HAL.

Medical Simulation Market Report Highlights:

  • Healthcare anatomical model dominated the products and services segment of the overall market in 2024, as these simulators are proving to be beneficial in the manufacturing and research industry for conducting trials.
  • The hospitals end-user segment is expected to expand at the fastest CAGR of 16.6% over the forecast period. Factors responsible for the growth are the gradual shift of focus on advanced learning and increasing focus on minimizing errors.
  • Procedural rehearsal technology is expected to be the largest technology segment. The rising number of medical errors leading to increasing demand for patient safety is expected to boost the demand for procedure rehearsal technology.
  • The Asia Pacific region is anticipated to register rapid growth in the forthcoming years owing to the growing healthcare IT spending and rapidly evolving healthcare infrastructure.
  • In February 2022, Surgical Science joined Mimic Technologies, thus expanding its foothold in the robotic surgery segment.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Segment Definition
      • 1.1.1.1 Product & Services Segment
      • 1.1.1.2 Technology Segment
      • 1.1.1.3 End Use Segment
  • 1.2 Regional Scope
    • 1.2.1 Estimates and Forecast Timeline
  • 1.3 Objectives
    • 1.3.1 Objective - 1
    • 1.3.2 Objective - 2
    • 1.3.3 Objective - 3
  • 1.4 Research Methodology
  • 1.5 Information Procurement
    • 1.5.1 Purchased Database
    • 1.5.2 GVR's Internal Database
    • 1.5.3 Secondary Sources
    • 1.5.4 Primary Research
    • 1.5.5 Details of Primary Research
  • 1.6 Information or Data Analysis
    • 1.6.1 Data Analysis Models
  • 1.7 Market Formulation & Validation
  • 1.8 Model Details
    • 1.8.1 Consensus-Based Estimates & Forecasting
      • 1.8.1.1 Commodity Flow Analysis (Model 1)
        • 1.8.1.1.1 Segment-Level Company Revenue Estimates: A Key Example
      • 1.8.1.2 Parent market Analysis
      • 1.8.1.3 Secondary reliable published data
      • 1.8.1.4 Top-Down market estimation
      • 1.8.1.5 Country-based segment share calculation
      • 1.8.1.6 Medical Simulation Market: CAGR Calculation
  • 1.9 List of Secondary Sources
  • 1.10 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Outlook
  • 2.3 Competitive Scenario

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Growing emphasis on patient safety and outcomes
      • 3.1.1.2 Shortage of qualified healthcare professionals
      • 3.1.1.3 Rising use of simulation, with a growing demand for innovative and custom training approaches to prevent medical errors
      • 3.1.1.4 Limited access to patients for educational and clinical development purposes
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 High cost of simulators and limited investment in simulation systems
      • 3.1.2.2 Inadequately designed medical simulation equipment
  • 3.2 Business Environment Analysis Tools
    • 3.2.1 Porter's Five Forces Analysis
    • 3.2.2 PESTL Analysis
  • 3.3 Technology Overview
    • 3.3.1 Virtual Reality (VR) and Augmented Reality (AR)
    • 3.3.2 Artificial Intelligence (AI)
    • 3.3.3 Gamification
    • 3.3.4 Use of Multidisciplinary Approach in the Development of Simulators
    • 3.3.5 3D Printing
    • 3.3.6 HCIT/EMR-EHR
  • 3.4 Impact of COVID-19 Pandemic
  • 3.5 Estimated Number of End Users Per Product Type, at Regional Level

Chapter 4 Medical Simulation Market: Product & Services Estimates & Trend Analysis

  • 4.1 Medical Simulation Product & Services Market: Segment Dashboard
  • 4.2 Product Movement & Market Share Analysis, 2024 & 2030
  • 4.3 Global Medical Simulation Market, Market Estimates & Forecast, by Product & Services
    • 4.3.1 Healthcare Anatomical Models
      • 4.3.1.1 Healthcare anatomical models market, 2018 - 2030 (USD Million)
      • 4.3.1.2 Type 1
        • 4.3.1.2.1 Patient Simulators
          • 4.3.1.2.1.1 Patient simulators market, 2018 - 2030 (USD Million)
          • 4.3.1.2.1.2 Adult
            • 4.3.1.2.1.2.1 Adult market, 2018 - 2030 (USD Million)
          • 4.3.1.2.1.3 Pediatrics and Baby Care
            • 4.3.1.2.1.3.1 Pediatrics and baby care market, 2018 - 2030 (USD Million)
        • 4.3.1.2.2 Task Trainers
      • 4.3.1.2.2.1Task trainers market, 2018 - 2030 (USD Million)
      • 4.3.1.3 By Fidelity Type
        • 4.3.1.3.1 Low-fidelity
          • 4.3.1.3.1.1 Low-fidelity market, 2018 - 2030 (USD Million)
        • 4.3.1.3.2 Medium-fidelity
          • 4.3.1.3.2.1 Medium-fidelity simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.3.3 High-fidelity
          • 4.3.1.3.3.1 High-fidelity simulators market, 2018 - 2030 (USD Million)
      • 4.3.1.4 Type 2
        • 4.3.1.4.1 Interventional/Surgical Simulators
          • 4.3.1.4.1.1 Interventional/surgical simulators market, 2018 - 2030 (USD Million)
          • 4.3.1.4.1.2 Laproscopic Surgical Simulators
            • 4.3.1.4.1.2.1 Laproscopic surgical simulators market, 2018 - 2030 (USD Million)
          • 4.3.1.4.1.3 Gynecology Simulators
            • 4.3.1.4.1.3.1 Gynecology simulators market, 2018 - 2030 (USD Million)
          • 4.3.1.4.1.4 Cardiovascular Simulators
            • 4.3.1.4.1.4.1 Cardiovascular simulators market, 2018 - 2030 (USD Million)
          • 4.3.1.4.1.5 Arthroscopic Surgical Simulators
            • 4.3.1.4.1.5.1 Arthroscopic surgical simulators market, 2018 - 2030 (USD Million)
          • 4.3.1.4.1.6 Spine Surgical Simulators
            • 4.3.1.4.1.6.1 Spine surgical simulators market, 2018 - 2030 (USD Million)
          • 4.3.1.4.1.7 Other Interventional/Surgical Simulators
            • 4.3.1.4.1.7.1 Other interventional/surgical simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.2 Endovascular Simulators
          • 4.3.1.4.2.1 Endovascular simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.3 Ultrasound Simulators
          • 4.3.1.6.3.1 Ultrasound simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.4 Dental Simulators
          • 4.3.1.4.4.1 Dental simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.5 Eye Simulators
          • 4.3.1.4.5.1 Eye simulators market, 2018 - 2030 (USD Million)
    • 4.3.2 Healthcare Simulation Software (Inclusive of Web-Based Simulators)
      • 4.3.2.1 Healthcare simulation software market, 2018 - 2030 (USD Million)
    • 4.3.3 Simulation Training Services
      • 4.3.3.1 Simulation training services market, 2018 - 2030 (USD Million)

Chapter 5 Medical Simulation Market: Technology Estimates & Trend Analysis

  • 5.1 Medical Simulation Technology Market: Segment Dashboard
  • 5.2 Technology Movement & Market Share Analysis, 2024 & 2030
  • 5.3 Global Medical Simulation Market, Market Estimates & Forecast, by Technology
    • 5.3.1 Virtual Patient Simulation
      • 5.3.1.1 Virtual patient simulation market, 2018 - 2030 (USD Million)
    • 5.3.2 3D Printing
      • 5.3.2.1 3D printing market, 2018 - 2030 (USD Million)
    • 5.3.3 Procedure Rehearsal Technology
      • 5.3.3.1 Procedure rehearsal technology market, 2018 - 2030 (USD Million)

Chapter 6 Medical Simulation Market: End Use Estimates & Trend Analysis

  • 6.1 Medical Simulation End Use Market: Segment Dashboard
  • 6.2 Instrument Movement & Market Share Analysis, 2024 & 2030
  • 6.3 Global Medical Simulation Market, Market Estimates & Forecast, by End Use
    • 6.3.1 Hospitals
      • 6.3.1.1 Hospitals market, 2018 - 2030 (USD Million)
    • 6.3.2 Research
      • 6.3.2.1 Research market, 2018 - 2030 (USD Million)
      • 6.3.2.2 Medical Device Companies
        • 6.3.2.2.1 Medical device companies market, 2018 - 2030 (USD Million)
      • 6.3.2.3 Others
        • 6.3.2.3.1 Others market, 2018 - 2030 (USD Million)
    • 6.3.3 Academic Institutes
      • 6.3.3.1 Academic institutes market, 2018 - 2030 (USD Million)
    • 6.3.4 Military Organizations
      • 6.3.4.1 Military organizations, 2018 - 2030 (USD Million)

Chapter 7 Regional Outlook

  • 7.1 Regional Outlook
  • 7.2 Medical Simulation Market by Region: Key Marketplace Takeaway
  • 7.3 North America
    • 7.3.1 North America Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
    • 7.3.2 U.S.
      • 7.3.2.1 Key country dynamics
      • 7.3.2.2 U.S. medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.3.2.3 Competitive scenario
      • 7.3.2.4 Regulatory scenario
    • 7.3.3 Canada
      • 7.3.3.1 Key country dynamics
      • 7.3.3.2 Canada medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.3.3.3 Competitive scenario
      • 7.3.3.4 Regulatory scenario
    • 7.3.4 Mexico
      • 7.3.4.1 Key country dynamics
      • 7.3.4.2 Mexico medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.3.4.3 Competitive scenario
      • 7.3.4.4 Regulatory scenario
  • 7.4 Europe
    • 7.4.1 Europe Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
    • 7.4.2 UK
      • 7.4.2.1 Key country dynamics
      • 7.4.2.2 UK medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.4.2.3 Competitive scenario
      • 7.4.2.4 Regulatory scenario
    • 7.4.3 Germany
      • 7.4.3.1 Key country dynamics
      • 7.4.3.2 Germany medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.4.3.3 Competitive scenario
      • 7.4.3.4 Regulatory scenario
    • 7.4.4 France
      • 7.4.4.1 Key country dynamics
      • 7.4.4.2 France medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.4.4.3 Competitive scenario
      • 7.4.4.4 Regulatory scenario
    • 7.4.5 Italy
      • 7.4.5.1 Key country dynamics
      • 7.4.5.2 Italy medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.4.5.3 Competitive scenario
      • 7.4.5.4 Regulatory scenario
    • 7.4.6 Spain
      • 7.4.6.1 Key country dynamics
      • 7.4.6.2 Spain medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.4.6.3 Competitive scenario
      • 7.4.6.4 Regulatory and reimbursement scenario
    • 7.4.7 Denmark
      • 7.4.7.1 Key country dynamics
      • 7.4.7.2 Denmark medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.4.7.3 Competitive scenario
      • 7.4.7.4 Regulatory and reimbursement scenario
    • 7.4.8 Sweden
      • 7.4.8.1 Key country dynamics
      • 7.4.8.2 Sweden medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.4.8.3 Competitive scenario
      • 7.4.8.4 Regulatory scenario
    • 7.4.9 Norway
      • 7.4.9.1 Key country dynamics
      • 7.4.9.2 Norway medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.4.9.3 Competitive scenario
      • 7.4.9.4 Regulatory and reimbursement scenario
  • 7.5 Asia Pacific
    • 7.5.1 Asia Pacific Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
    • 7.5.2 Japan
      • 7.5.2.1 Key country dynamics
      • 7.5.2.2 Japan medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.5.2.3 Competitive scenario
      • 7.5.2.4 Regulatory scenario
    • 7.5.3 China
      • 7.5.3.1 Key country dynamics
      • 7.5.3.2 China medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.5.3.3 Competitive scenario
      • 7.5.3.4 Regulatory scenario
    • 7.5.4 India
      • 7.5.4.1 Key country dynamics
      • 7.5.4.2 India medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.5.4.3 Competitive scenario
      • 7.5.4.4 Regulatory scenario
    • 7.5.5 Australia
      • 7.5.5.1 Key country dynamics
      • 7.5.5.2 Australia medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.5.5.3 Competitive scenario
      • 7.5.5.4 Regulatory scenario
    • 7.5.6 South Korea
      • 7.5.6.1 Key country dynamics
      • 7.5.6.2 South Korea medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.5.6.3 Competitive scenario
      • 7.5.6.4 Regulatory scenario
    • 7.5.7 Thailand
      • 7.5.7.1 Key country dynamics
      • 7.5.7.2 Thailand medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.5.7.3 Competitive scenario
      • 7.5.7.4 Regulatory scenario
  • 7.6 Latin America
    • 7.6.1 Latin America Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
    • 7.6.2 Brazil
      • 7.6.2.1 Key country dynamics
      • 7.6.2.2 Brazil medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.6.2.3 Competitive scenario
      • 7.6.2.4 Regulatory scenario
    • 7.6.3 Argentina
      • 7.6.3.1 Key country dynamics
      • 7.6.3.2 Argentina medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.6.3.3 Competitive scenario
      • 7.6.3.4 Regulatory scenario
  • 7.7 Middle East & Africa (MEA)
    • 7.7.1 MEA Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
    • 7.7.2 South Africa
      • 7.7.2.1 Key country dynamics
      • 7.7.2.2 South Africa medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.7.2.3 Competitive scenario
      • 7.7.2.4 Regulatory scenario
    • 7.7.3 Saudi Arabia
      • 7.7.3.1 Key country dynamics
      • 7.7.3.2 Saudi Arabia medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.7.3.3 Competitive scenario
      • 7.7.3.4 Regulatory scenario
    • 7.7.4 UAE
      • 7.7.4.1 Key country dynamics
      • 7.7.4.2 UAE medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.7.4.3 Competitive scenario
      • 7.7.4.4 Regulatory scenario
    • 7.7.5 Kuwait
      • 7.7.5.1 Key country dynamics
      • 7.7.5.2 Kuwait medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
      • 7.7.5.3 Competitive scenario
      • 7.7.5.4 Regulatory scenario

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. CAE, Inc. (Madison Industries acquired CAE healthcare division in October 2023)
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Laerdal Medical
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. 3D Systems, Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Simulab Corporation
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Limbs & Things Ltd
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Simulaids
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Kyoto Kagaku Co., Ltd
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Gaumard Scientific
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Mentice
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Surgical Science Sweden AB
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Intelligent Ultrasound
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Operative Experience, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Cardionics, Inc.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. VirtaMed AG
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. SYNBONE AG
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. IngMar Medical
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Product benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. TruCorp
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Product benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. KaVo Dental
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Product benchmarking
      • 8.4.18.4. Strategic initiatives
    • 8.4.19. Simendo
      • 8.4.19.1. Company overview
      • 8.4.19.2. Financial performance
      • 8.4.19.3. Product benchmarking
      • 8.4.19.4. Strategic initiatives
    • 8.4.20. Haag-Streit
      • 8.4.20.1. Company overview
      • 8.4.20.2. Financial performance
      • 8.4.20.3. Product benchmarking
      • 8.4.20.4. Strategic initiatives
    • 8.4.21. Symgery
      • 8.4.21.1. Company overview
      • 8.4.21.2. Financial performance
      • 8.4.21.3. Product benchmarking
      • 8.4.21.4. Strategic initiatives
    • 8.4.22. HRV Simulation
      • 8.4.22.1. Company overview
      • 8.4.22.2. Financial performance
      • 8.4.22.3. Product benchmarking
      • 8.4.22.4. Strategic initiatives
    • 8.4.23. Synaptive Medical
      • 8.4.23.1. Company overview
      • 8.4.23.2. Financial performance
      • 8.4.23.3. Product benchmarking
      • 8.4.23.4. Strategic initiatives
    • 8.4.24. Inovus Limited
      • 8.4.24.1. Company overview
      • 8.4.24.2. Financial performance
      • 8.4.24.3. Product benchmarking
      • 8.4.24.4. Strategic initiatives